[1]薛 堃,邢秋娟,吴 佶,等.益气化瘀补肾方联合抗阻运动治疗原发性骨质疏松症疗效研究[J].陕西中医,2022,(3):321-324.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.012]
　XUE Kun,XING Qiujuan,WU Ji,et al.Effect of Yiqi Huayu Bushen decoction combined with anti-obstructive exercise in the treatment of primary osteoporosis[J].,2022,(3):321-324.[doi:DOI:10.3969/j.issn.1000-7369.2022.03.012]
点击复制

益气化瘀补肾方联合抗阻运动治疗原发性骨质疏松症疗效研究
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2022年3期
页码:
321-324
栏目:
临床研究
出版日期:
2022-03-05

文章信息/Info

Title:
Effect of Yiqi Huayu Bushen decoction combined with anti-obstructive exercise in the treatment of primary osteoporosis
作者:
薛 堃1; 邢秋娟1; 吴 佶1; 黄春水1; 暴 洁1; 赵 芸1; 陆虞荪1; 焦丹丽1; 2
(1.上海中医药大学附属龙华医院,上海 200051; 2.上海中医药大学,上海 200032)
Author(s):
XUE Kun; XING Qiujuan; WU Ji; HUANG Chunshui; BAO Jie; ZHAO Yun; LU Yusun; JIAO Danli
(Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200051,China)
关键词:
原发性骨质疏松症;  益气化瘀补肾方;  抗阻运动;  骨密度;  骨钙素
Keywords:
Primary osteoporosis;  Yiqi Huayu Bushen decoction;  Resistance exercise;  Bone mineral density;  Osteocalcin
分类号:
R 68
DOI:
DOI:10.3969/j.issn.1000-7369.2022.03.012
文献标志码:
A
摘要:
目的:探讨益气化瘀补肾方联合抗阻运动治疗原发性骨质疏松症的疗效及对骨密度(BMD)、骨钙素(BGP)的影响。方法:选择150例原发性骨质疏松症患者,采用抽签法分为试验组(n=50)、联合对照组(n=50)、对照组(n=50)。试验组给予抗阻运动加内服益气化瘀补肾方治疗,联合对照组给予抗阻运动加口服阿伦磷酸钠治疗,对照组予口服阿伦磷酸钠治疗,三组均连续治疗3个月。比较三组临床疗效、BMD、生活质量评分(SF-36)、BGP、骨碱性磷酸酶(BALP)、β-I型胶原羧基末端交联肽(β-CTX)、视觉模拟评分(VAS)、中医证候总积分变化情况。结果:治疗后,试验组总有效率96.00%,联合对照组总有效率78.00%,对照组总有效率72.00%,三组比较差异有统计学意义(P<0.05)。治疗后,试验组BMD、SF-36评分高于联合对照组和对照组,差异有统计学意义(均P<0.05)。治疗后,试验组BGP水平高于联合对照组和对照组,差异有统计学意义(均P<0.05)。治疗后,试验组BALP、β-CTX水平低于联合对照组和对照组,差异有统计学意义(均P<0.05)。治疗后,试验组VAS评分、中医证候总积分低于联合对照组和对照组,差异有统计学意义(均P<0.05)。结论:应用益气化瘀补肾方联合抗阻运动治疗原发性骨质疏松症疗效较好,可有效改善患者BMD、BGP水平。
Abstract:
Objective:To investigate the curative effect of Yiqi Huayu Bushen decoction combined with anti-obstructive exercise in the treatment of primary osteoporosis and its effect on bone mineral density(BMD)and osteocalcin(BGP).Methods:150 patients with primary osteoporosis were selected and divided into experimental group(n=50),combined control group(n=50)and control group(n=50)by lottery.The experimental group were given anti-resistance exercise and Yiqi Huayu Bushen decoction.The combined control group were given anti-resistance exercise and alendronate.The control group were given alendronate.All the groups were continuously treated for 3 months.Clinical efficacy,BMD,SF-36,BGP,BALP,β-CTX,VAS and TCM syndrome score were compared.Results:After treatment, the total effective rate of the experimental group was 96.00%,the total effective rate of the combined control group was 78.00%,and the total effective rate of the control group was 72.00%,difference statistically significant(P<0.05).After treatment,BMD and SF-36 scores in the experimental group were higher than those in the combined control group and the control group, difference statistically significant(all P<0.05).After treatment,the level of BGP in the experimental group was higher than those in the combined control group and the control group,difference statistically significant(all P<0.05).The levels of BALP and β-CTX in the experimental group were lower than those in the combined control group and the control group,difference statistically significant(all P<0.05).After treatment,VAS score and TCM syndrome score of the experimental group were lower than those in the combined control group and the control group,difference statistically significant(all P<0.05).Conclusion:The application of Yiqi Huayu Bushen decoction combined with anti-obstructive exercise has significant effect on the treatment of primary osteoporosis,which can effectively improve BMD and BGP levels.

参考文献/References:

[1] 李 洺,赵 宇,马 丁,等.女性绝经后骨质疏松症患者血清铁蛋白、同源拮抗物表达水平及临床意义[J].陕西医学杂志,2020,49(10):1266-1269.
[2] 金 华.自拟补肾强骨汤治疗骨质疏松症的疗效及对骨代谢指标的影响[J].光明中医,2020,35(3):339-341.
[3] 胡正刚,田俊松.补肾活血汤联合骨化三醇治疗骨质疏松性脊椎骨折的疗效及对患者骨密度、骨代谢的影响[J].四川中医,2020,38(2):155-158.
[4] 唐 杏,孙玉明.不同运动方式对骨质疏松症的影响[J].中外医学研究,2019,17(21):183-l85.
[5] Kornoukhova LA,Emanuel VL,Denisov NL.The role of adipose tissue and laboratory predictors of primary osteoporosis[J].Klinicheskaia Laboratornaia Diagnostika,2020,65(4):205-211.
[6] 王 璐,许鸿新,张思伟,等.补肾健脾针刺法治疗老年男性原发性骨质疏松症的临床疗效评估研究[J].中国骨质疏松杂志,2019,25(2):224-227.
[7] 葛继荣,刘柏龄,孙树椿,等.中医药防治原发性骨质疏松症专家共识[J].中国骨质疏松杂志,2015,21(9):1023-1028.
[8] 袁 红,李 俊,翁育清,等.唑来膦酸治疗COPD患者骨质疏松症的疗效及对肺功能影响的分析[J].中国骨质疏松杂志,2019,25(3):358-361.
[9] 刘忠厚.骨质疏松症的诊断和筛选[J].中国老年学杂志,1995,15(1):53.
[10] 葛继荣,刘柏龄,孙树椿,等.中医药防治原发性骨质疏松症专家共识[J].中国骨质疏松杂志,2015,21(9):1023-1028.
[11] 沈自尹.中医虚证辨证参考标准[J].中西医结合杂志,1983,3(2):117.
[12] 王 阶,姚魁武.血瘀证诊断标准研究述要及思考[J].中国中医药信息杂志,2004,11(1):17-19.
[13] 张绍岚,何小花.疾病康复[M].北京:人民卫生出版社,2014:225-229.
[14] 胡 煜,郑 健,邱习勤.有氧运动联合渐进式抗阻运动治疗老年人骨质疏松症临床疗效观察[J].南京体育学院学报,2017,16(4):23-27.
[15] 国家中医药管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:356.
[16] 国家中医药管理局.中医病证疗效诊断标准[S].南京:南京大学出版社,1994:186-187.
[17] 成 洁,王 颖,吉健华,等.骨疏康胶囊治疗肾阳虚型骨质疏松症疗效及对患者骨代谢影响[J].陕西中医,2019,40(9):1232-1234,1250.
[18] 刘 峰,孙庆山,白田雨.温肾强骨方对肿瘤中后期并发骨质疏松症患者骨密度、骨形成及骨吸收的影响[J].陕西中医,2021,42(6):712-715.
[19] Cairoli E,Palmieri S,Goggi G,et al.Denosumab or oral bisphosphonates in primary osteoporosis:A“real-life” study[J].Journal of Endocrinological Investigation,2018,41(17):1-9.
[20] Shen ZF,Zhu GF,Qian LF,et al.Yi Jin Jing for primary osteoporosis in the elderly: A clinical trial[J].Journal of Acupuncture and Tuinaence,2018,16(2):104-108.
[21] 白俊卿.丹参川芎嗪注射液联合盐酸倍他司汀治疗椎基底动脉系统供血不足疗效及对预后生存质量的影响[J].陕西中医,2018,39(3):301-303.
[22] 王琳琳,卫志锋,潘 星.高血压肾病采用丹参多酚酸盐联合缬沙坦治疗对临床症状及实验室指标的影响分析[J].陕西中医,2016,37(2):158-160.
[23] 马腾骏,凌 峰,杨建安,等.益气化瘀补肾方对腰椎间盘突出症患者软组织张力的影响[J].中医学报,2019,34(4):827-829.

相似文献/References:

[1]董 琪,张快强,昝 强,等.刘德玉教授论治原发性骨质疏松症经验*[J].陕西中医,2020,(2):226.
[2]薛 磊,冉 宇,李忠泽,等.金天格胶囊治疗原发性骨质疏松症疗效研究[J].陕西中医,2023,(7):873.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.010]
　XUE Lei,RAN Yu,LI Zhongze,et al.Effect study on Jintiange capsule in treatment of primary osteoporosis[J].,2023,(3):873.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.010]

备注/Memo

备注/Memo:
基金项目:上海市自然科学基金资助项目(15ZR1441600); 上海市卫生健康委员会中医药科研项目(2020LP012); 上海市卫生和计划生育委员会中医药科研专项课题(2016LP053); 上海市卫生健康委员会中医优势病种培育项目[ZY(2018-2020)-ZYBZ-24]; 上海市长宁区医学硕博士创新人才基地项目(RCJD2021B07); 上海市长宁区健康委员会科研课题(2019Z006)
更新日期/Last Update: 2022-03-09